{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:40:12Z","timestamp":1791362412276,"version":"4.3.1"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["493624332"],"award-info":[{"award-number":["493624332"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Center for Cardiovascular Research","doi-asserted-by":"publisher","award":["81X3200126"],"award-info":[{"award-number":["81X3200126"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amandus and Barbara Pauli Foundation"},{"name":"Heinrich and Fritz Riese Foundation"},{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015213","name":"Network of University Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Patients with cardiovascular disease (CVD) have an increased risk of developing severe respiratory infections, including COVID-19. However, the underlying molecular mechanisms are not completely understood. It has been previously shown that CVD predisposes to an altered responsiveness to subsequent inflammatory triggers by an imprinted epigenetic memory in innate immune cells. Therefore, we hypothesized that patients with pre-existing atherosclerotic cardiovascular disease (ASCVD) and COVID-19 display a dysregulated inflammatory response compared to patients without ASCVD due to epigenetically altered immune cells leading to increased disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Single-cell RNA sequencing revealed a dysregulated myeloid immune response with hyperinflammatory and immunosuppressive features in patients with ASCVD and moderate COVID-19. Assay for Transposase-Accessible Chromatin sequencing and in vitro experiments with isolated monocytes infected with SARS-CoV-2 showed epigenetic priming of monocytes from patients with ASCVD towards increased expression of inflammatory mediators and type I interferon signalling. In a German nationwide cohort (NAPKON), using multiplex cytokine assays, enzyme-linked immunosorbent assays, and bulk-RNA sequencing, we confirmed that patients with ASCVD display an exaggerated inflammatory response during moderate COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates that patients with ASCVD show a dysregulated myeloid immune response in moderate COVID-19 disease. Mechanistically, epigenetic imprinting sensitizes myeloid cells of patients with ASCVD to an exaggerated type I interferon-associated immune response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cvr\/cvaf268","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:02:49Z","timestamp":1765544569000},"page":"81-97","source":"Crossref","is-referenced-by-count":2,"title":["Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells"],"prefix":"10.1093","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1717-0706","authenticated-orcid":false,"given":"Julian","family":"Leberzammer","sequence":"first","affiliation":[{"name":"Department of Medicine, Cardiology, Goethe University Hospital , Frankfurt ,","place":["Germany"]},{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley Tyler","family":"Abplanalp","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Grikscheit","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, Goethe University , Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil G","family":"Solomonidis","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone-Franziska","family":"Glaser","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Schuhmacher","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Merten","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gligorije","family":"Jeremijev","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology, Goethe University Hospital , Frankfurt ,","place":["Germany"]},{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"Wilken-Schmitz","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Korth","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3217-5449","authenticated-orcid":false,"given":"David","family":"John","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-4549","authenticated-orcid":false,"given":"Stefan","family":"G\u00fcnther","sequence":"additional","affiliation":[{"name":"Max Planck Institute for Heart and Lung Research , Bad Nauheim ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Kuenne","sequence":"additional","affiliation":[{"name":"Max Planck Institute for Heart and Lung Research , Bad Nauheim ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-9530","authenticated-orcid":false,"given":"Mario","family":"Looso","sequence":"additional","affiliation":[{"name":"Max Planck Institute for Heart and Lung Research , Bad Nauheim ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanil","family":"Valasarajan","sequence":"additional","affiliation":[{"name":"Max Planck Institute for Heart and Lung Research , Bad Nauheim ,","place":["Germany"]},{"name":"Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Cardio-Pulmonary Institute (CPI), Member of the German Center for Lung Research (DZL) , Giessen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-2547","authenticated-orcid":false,"given":"Vladimir","family":"Benes","sequence":"additional","affiliation":[{"name":"Genomics Core Facility, European Molecular Biology Laboratory , Heidelberg 69117 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferris","family":"Jung","sequence":"additional","affiliation":[{"name":"Genomics Core Facility, European Molecular Biology Laboratory , Heidelberg 69117 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivianne","family":"Niehaus","sequence":"additional","affiliation":[{"name":"Genomics Core Facility, European Molecular Biology Laboratory , Heidelberg 69117 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Anton","sequence":"additional","affiliation":[{"name":"Medical School OWL, Bielefeld University , Bielefeld ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8429-2826","authenticated-orcid":false,"given":"Christoph","family":"Stellbrink","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Internal Intensive Care Medicine, Bielefeld University, Medical School and University Medical Center OWL, Hospital Bielefeld , Bielefeld ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8745-8510","authenticated-orcid":false,"given":"Christoph","family":"R\u00f6mmele","sequence":"additional","affiliation":[{"name":"Internal Medicine III\u2014Gastroenterology and Infectious Diseases, University Hospital of Augsburg , Augsburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"G\u00f6pel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Infectious Diseases, University Hospital T\u00fcbingen , T\u00fcbingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soni Savai","family":"Pullamsetti","sequence":"additional","affiliation":[{"name":"Max Planck Institute for Heart and Lung Research , Bad Nauheim ,","place":["Germany"]},{"name":"Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Cardio-Pulmonary Institute (CPI), Member of the German Center for Lung Research (DZL) , Giessen ,","place":["Germany"]},{"name":"Institute for Lung Health (ILH), Justus-Liebig University , Giessen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Vehreschild","sequence":"additional","affiliation":[{"name":"Institute for Digital Medicine and Clinical Data Science, Goethe University Frankfurt , Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vehreschild","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Oncology, Infectious Disease, Goethe University Hospital , Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ciesek","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Centre for Infection Research, External Partner Site , Frankfurt ,","place":["Germany"]},{"name":"Fraunhofer Institute for Molecular Biology and Applied Ecology, Branch Translational Medicine and Pharmacology , Frankfurt am Main ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Leistner","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology, Goethe University Hospital , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1711-5819","authenticated-orcid":false,"given":"Andreas M","family":"Zeiher","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1045-2436","authenticated-orcid":false,"given":"Stefanie","family":"Dimmeler","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6409-9279","authenticated-orcid":false,"given":"Sebastian","family":"Cremer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardiology, Goethe University Hospital , Frankfurt ,","place":["Germany"]},{"name":"Institute of Cardiovascular Regeneration, Goethe University , Frankfurt ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research , Berlin (partner site Rhine-Main) ,","place":["Germany"]},{"name":"Cardiopulmonary Institute (CPI) , Frankfurt 60590 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"2026022323464994100_cvaf268-B1","author":"WHO"},{"key":"2026022323464994100_cvaf268-B2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.120.051828","article-title":"Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study","volume":"143","author":"Pellegrini","year":"2021","journal-title":"Circulation"},{"key":"2026022323464994100_cvaf268-B3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2026022323464994100_cvaf268-B4","first-page":"330","article-title":"Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews","volume":"7","author":"Harrison","year":"2021","journal-title":"Eur Heart J\u2014Qual Care Clin Outcomes"},{"key":"2026022323464994100_cvaf268-B5","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2026022323464994100_cvaf268-B6","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.jacc.2020.09.549","article-title":"Prognostic impact of prior heart failure in patients hospitalized with COVID-19","volume":"76","author":"Alvarez-Garcia","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026022323464994100_cvaf268-B7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2020.11.003","article-title":"Clinical outcomes in patients with heart failure hospitalized with COVID-19","volume":"9","author":"Bhatt","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2026022323464994100_cvaf268-B8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"2026022323464994100_cvaf268-B9","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/s41467-022-28508-0","article-title":"Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection","volume":"13","author":"Pekayvaz","year":"2022","journal-title":"Nat Commun"},{"key":"2026022323464994100_cvaf268-B10","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell"},{"key":"2026022323464994100_cvaf268-B11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00392-020-01769-9","article-title":"Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry","volume":"110","author":"Cremer","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2026022323464994100_cvaf268-B12","doi-asserted-by":"crossref","first-page":"e2240037","DOI":"10.1001\/jamanetworkopen.2022.40037","article-title":"Factors associated with severe COVID-19 among vaccinated adults treated in US veterans affairs hospitals","volume":"5","author":"Vo","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026022323464994100_cvaf268-B13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15585\/mmwr.mm7101a4","article-title":"Risk factors for severe COVID-19 outcomes among persons aged \u226518 years who completed a primary COVID-19 vaccination series\u2014465 health care facilities, United States, December 2020-October 2021","volume":"71","author":"Yek","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026022323464994100_cvaf268-B14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2026022323464994100_cvaf268-B15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"},{"key":"2026022323464994100_cvaf268-B16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2016.10.019","article-title":"Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo","volume":"254","author":"Bekkering","year":"2016","journal-title":"Atherosclerosis"},{"key":"2026022323464994100_cvaf268-B17","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.ATV.0000156877.94472.a5","article-title":"Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?","volume":"25","author":"Coller","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026022323464994100_cvaf268-B18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"2026022323464994100_cvaf268-B19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jacbts.2020.04.001","article-title":"The heart in COVID-19: primary target or secondary bystander?","volume":"5","author":"Libby","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"2026022323464994100_cvaf268-B20","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.immuni.2020.11.017","article-title":"Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19","volume":"53","author":"Bernardes","year":"2020","journal-title":"Immunity"},{"key":"2026022323464994100_cvaf268-B21","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41467-021-21702-6","article-title":"Deciphering the state of immune silence in fatal COVID-19 patients","volume":"12","author":"Bost","year":"2021","journal-title":"Nat Commun"},{"key":"2026022323464994100_cvaf268-B22","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","article-title":"COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas","volume":"184","author":"Ren","year":"2021","journal-title":"Cell"},{"key":"2026022323464994100_cvaf268-B23","doi-asserted-by":"crossref","first-page":"e20210582","DOI":"10.1084\/jem.20210582","article-title":"Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19","volume":"218","author":"Wilk","year":"2021","journal-title":"J Exp Med"},{"key":"2026022323464994100_cvaf268-B24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat Med"},{"key":"2026022323464994100_cvaf268-B25","doi-asserted-by":"crossref","first-page":"eabe9599","DOI":"10.1126\/scitranslmed.abe9599","article-title":"Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro","volume":"13","author":"Reyes","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026022323464994100_cvaf268-B26","doi-asserted-by":"crossref","first-page":"e1308","DOI":"10.1002\/cti2.1308","article-title":"No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID-19 disease","volume":"10","author":"Alquicira-Hernandez","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"2026022323464994100_cvaf268-B27","doi-asserted-by":"crossref","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"5","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci Immunol"},{"key":"2026022323464994100_cvaf268-B28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"key":"2026022323464994100_cvaf268-B29","doi-asserted-by":"crossref","first-page":"103325","DOI":"10.1016\/j.isci.2021.103325","article-title":"Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19","volume":"24","author":"Schulthei\u00df","year":"2021","journal-title":"iScience"},{"key":"2026022323464994100_cvaf268-B30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","article-title":"Single-cell multi-omics analysis of the immune response in COVID-19","volume":"27","author":"Stephenson","year":"2021","journal-title":"Nat Med"},{"key":"2026022323464994100_cvaf268-B31","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"Wendisch","year":"2021","journal-title":"Cell"},{"key":"2026022323464994100_cvaf268-B32","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/s41467-023-37425-9","article-title":"TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques","volume":"14","author":"Upadhyay","year":"2023","journal-title":"Nat Commun"},{"key":"2026022323464994100_cvaf268-B33","doi-asserted-by":"crossref","first-page":"e1003731","DOI":"10.1371\/journal.pcbi.1003731","article-title":"Iregulon: from a gene list to a gene regulatory network using large motif and track collections","volume":"10","author":"Janky","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"2026022323464994100_cvaf268-B34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2026022323464994100_cvaf268-B35","doi-asserted-by":"crossref","first-page":"e20201241","DOI":"10.1084\/jem.20201241","article-title":"Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling","volume":"217","author":"Israelow","year":"2020","journal-title":"J Exp Med"},{"key":"2026022323464994100_cvaf268-B36","doi-asserted-by":"crossref","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"2026022323464994100_cvaf268-B37","doi-asserted-by":"crossref","first-page":"eadg0033","DOI":"10.1126\/sciimmunol.adg0033","article-title":"Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques","volume":"8","author":"Viox","year":"2023","journal-title":"Sci Immunol"},{"key":"2026022323464994100_cvaf268-B38","doi-asserted-by":"crossref","first-page":"1101808","DOI":"10.3389\/fimmu.2023.1101808","article-title":"Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia","volume":"14","author":"Jeon","year":"2023","journal-title":"Front Immunol"},{"key":"2026022323464994100_cvaf268-B39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41421-021-00296-9","article-title":"Dysregulated hematopoiesis in bone marrow marks severe COVID-19","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov"},{"key":"2026022323464994100_cvaf268-B40","doi-asserted-by":"crossref","first-page":"e60939","DOI":"10.7554\/eLife.60939","article-title":"Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease","volume":"9","author":"Noz","year":"2020","journal-title":"Elife"},{"key":"2026022323464994100_cvaf268-B41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10654-022-00896-z","article-title":"The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics","volume":"37","author":"Schons","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"2026022323464994100_cvaf268-B42","doi-asserted-by":"crossref","first-page":"104302","DOI":"10.1016\/j.cellimm.2021.104302","article-title":"Myeloid-derived suppressor cells (MDSC): when good intentions go awry","volume":"362","author":"Sanchez-Pino","year":"2021","journal-title":"Cell Immunol"},{"key":"2026022323464994100_cvaf268-B43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","article-title":"An immune-cell signature of bacterial sepsis","volume":"26","author":"Reyes","year":"2020","journal-title":"Nat Med"},{"key":"2026022323464994100_cvaf268-B44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MOH.0000000000000395","article-title":"Dysregulated myelopoiesis and hematopoietic function following acute physiologic insult","volume":"25","author":"Loftus","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"2026022323464994100_cvaf268-B45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13073-020-00823-5","article-title":"Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients","volume":"13","author":"Aschenbrenner","year":"2021","journal-title":"Genome Med"},{"key":"2026022323464994100_cvaf268-B46","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1186\/cc14003","article-title":"Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients","volume":"18","author":"Darcy","year":"2014","journal-title":"Crit Care"},{"key":"2026022323464994100_cvaf268-B47","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1172\/JCI36264","article-title":"Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans","volume":"118","author":"De Santo","year":"2008","journal-title":"J Clin Invest"},{"key":"2026022323464994100_cvaf268-B48","doi-asserted-by":"crossref","first-page":"104346","DOI":"10.1016\/j.cellimm.2021.104346","article-title":"G-CSF promotes alloregulatory function of MDSCs through a c-Kit dependent mechanism","volume":"364","author":"Lee","year":"2021","journal-title":"Cell Immunol"},{"key":"2026022323464994100_cvaf268-B49","doi-asserted-by":"crossref","first-page":"12174","DOI":"10.1038\/s41598-021-91754-7","article-title":"A single transcript for the prognosis of disease severity in COVID-19 patients","volume":"11","author":"Lei","year":"2021","journal-title":"Sci Rep"},{"key":"2026022323464994100_cvaf268-B50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.chom.2020.12.016","article-title":"Induction of alarmin S100A8\/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19","volume":"29","author":"Guo","year":"2021","journal-title":"Cell Host Microbe"},{"key":"2026022323464994100_cvaf268-B51","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat Immunol"},{"key":"2026022323464994100_cvaf268-B52","doi-asserted-by":"crossref","first-page":"e0263968","DOI":"10.1371\/journal.pone.0263968","article-title":"A systematic review and meta-analyses of interleukin-1 receptor associated kinase 3 (IRAK3) action on inflammation in in vivo models for the study of sepsis","volume":"17","author":"Nguyen","year":"2022","journal-title":"PLoS One"},{"key":"2026022323464994100_cvaf268-B53","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4049\/jimmunol.1601982","article-title":"Immunomodulatory molecule IRAK-M balances macrophage polarization and determines macrophage responses during renal fibrosis","volume":"199","author":"Steiger","year":"2017","journal-title":"J Immunol"},{"key":"2026022323464994100_cvaf268-B54","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/eurheartj\/ehad093","article-title":"Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement","volume":"44","author":"Mas-Peiro","year":"2023","journal-title":"Eur Heart J"},{"key":"2026022323464994100_cvaf268-B55","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jaci.2020.02.034","article-title":"CD163 expression defines specific, IRF8-dependent, immune-modulatory macrophages in the bone marrow","volume":"146","author":"Fischer-Riepe","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026022323464994100_cvaf268-B56","doi-asserted-by":"crossref","first-page":"155236","DOI":"10.1016\/j.metabol.2022.155236","article-title":"SARS-CoV-2 infection impairs the insulin\/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1","volume":"133","author":"Shin","year":"2022","journal-title":"Metabolism"},{"key":"2026022323464994100_cvaf268-B57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat Immunol"},{"key":"2026022323464994100_cvaf268-B58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"2026022323464994100_cvaf268-B59","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41467-023-44524-0","article-title":"Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity","volume":"15","author":"Lin","year":"2024","journal-title":"Nat Commun"},{"key":"2026022323464994100_cvaf268-B60","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.immuni.2021.09.002","article-title":"Early IFN-\u03b1 signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19","volume":"54","author":"Kr\u00e4mer","year":"2021","journal-title":"Immunity"},{"key":"2026022323464994100_cvaf268-B61","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"key":"2026022323464994100_cvaf268-B62","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med"},{"key":"2026022323464994100_cvaf268-B63","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(22)01109-6","article-title":"Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"2026022323464994100_cvaf268-B64","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1093\/cid\/ciac724","article-title":"Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19 (September 2022)","volume":"78","author":"Bhimraj","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026022323464994100_cvaf268-B65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00408-021-00451-9","article-title":"Tocilizumab in hospitalized patients with COVID-19: a meta analysis of randomized controlled trials","volume":"199","author":"Selvaraj","year":"2021","journal-title":"Lung"},{"key":"2026022323464994100_cvaf268-B66","doi-asserted-by":"crossref","first-page":"107597","DOI":"10.1016\/j.isci.2023.107597","article-title":"Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19","volume":"26","author":"Shivram","year":"2023","journal-title":"iScience"},{"key":"2026022323464994100_cvaf268-B67","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40001-023-01072-z","article-title":"Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis","volume":"28","author":"Dahms","year":"2023","journal-title":"Eur J Med Res"},{"key":"2026022323464994100_cvaf268-B68","doi-asserted-by":"crossref","first-page":"100816","DOI":"10.1016\/j.lanepe.2023.100816","article-title":"Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales","volume":"37","author":"Bedston","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026022323464994100_cvaf268-B69","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"2026022323464994100_cvaf268-B70","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/s41591-023-02521-2","article-title":"Postacute sequelae of COVID-19 at 2 years","volume":"29","author":"Bowe","year":"2023","journal-title":"Nat Med"},{"key":"2026022323464994100_cvaf268-B71","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41591-024-02987-8","article-title":"Three-year outcomes of post-acute sequelae of COVID-19","volume":"30","author":"Cai","year":"2024","journal-title":"Nat Med"},{"key":"2026022323464994100_cvaf268-B72","doi-asserted-by":"crossref","first-page":"101619","DOI":"10.1016\/j.eclinm.2022.101619","article-title":"Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks","volume":"53","author":"Wang","year":"2022","journal-title":"eClinicalMedicine"},{"key":"2026022323464994100_cvaf268-B73","doi-asserted-by":"crossref","first-page":"e230010","DOI":"10.1001\/jamahealthforum.2023.0010","article-title":"One-year adverse outcomes among US adults with post\u2013COVID-19 condition vs those without COVID-19 in a large commercial insurance database","volume":"4","author":"DeVries","year":"2023","journal-title":"JAMA Health Forum"},{"key":"2026022323464994100_cvaf268-B74","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s44161-023-00220-2","article-title":"Excess cardiovascular mortality across multiple COVID-19 waves in the United States from March 2020 to March 2022","volume":"2","author":"Han","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"2026022323464994100_cvaf268-B75","doi-asserted-by":"crossref","first-page":"A42","DOI":"10.1093\/eurheartjsupp\/suac123","article-title":"The impact of COVID-19 and COVID vaccination on cardiovascular outcomes","volume":"25","author":"Akhtar","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"2026022323464994100_cvaf268-B76","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jacc.2022.12.006","article-title":"Impact of vaccination on Major adverse cardiovascular events in patients with COVID-19 infection","volume":"81","author":"Jiang","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026022323464994100_cvaf268-B77","doi-asserted-by":"crossref","first-page":"e029291","DOI":"10.1161\/JAHA.122.029291","article-title":"BNT162b2 or CoronaVac vaccinations are associated with a lower risk of myocardial infarction and stroke after SARS-CoV-2 infection among patients with cardiovascular disease","volume":"12","author":"Ye","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026022323464994100_cvaf268-B78","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","article-title":"Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions","volume":"12","author":"Goossens","year":"2010","journal-title":"Cell Metab"},{"key":"2026022323464994100_cvaf268-B79","doi-asserted-by":"crossref","first-page":"e20190459","DOI":"10.1084\/jem.20190459","article-title":"Type-I interferons in atherosclerosis","volume":"217","author":"Chen","year":"2019","journal-title":"J Exp Med"},{"key":"2026022323464994100_cvaf268-B80","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jchf.2018.10.011","article-title":"Effect of influenza on outcomes in patients with heart failure","volume":"7","author":"Panhwar Muhammad","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026022323464994100_cvaf268-B81","doi-asserted-by":"crossref","first-page":"e006746","DOI":"10.1161\/CIRCHEARTFAILURE.119.006746","article-title":"Infection-related hospitalization in heart failure with reduced ejection fraction","volume":"13","author":"Drozd","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026022323464994100_cvaf268-B82","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jacc.2021.03.001","article-title":"Incidence and outcomes of pneumonia in patients with heart failure","volume":"77","author":"Shen","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026022323464994100_cvaf268-B83","doi-asserted-by":"crossref","first-page":"e0264890","DOI":"10.1371\/journal.pone.0264890","article-title":"Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015-2017","volume":"17","author":"Kujawski","year":"2022","journal-title":"PLoS One"},{"key":"2026022323464994100_cvaf268-B84","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1038\/s41598-023-34028-8","article-title":"Impact of infection-related admission in patients with heart failure: a 10 years national cohort study","volume":"13","author":"Chen","year":"2023","journal-title":"Sci Rep"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvaf268\/65877265\/cvaf268.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/122\/1\/81\/65877265\/cvaf268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/122\/1\/81\/65877265\/cvaf268.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T04:47:10Z","timestamp":1771908430000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/122\/1\/81\/8379518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,13]]},"published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvaf268","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,13]]}}}